Recent SONN Stock Price | SONN Stock Predictions | |
$4.90 | +4797.96% |
$240.00 |
Recent SONN Analyst Ratings Breakdown, Making SONN Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 1 | 1 | 3 | 3 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 0 | 0 | 0 | 0 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.0 | 1.0 | 1.0 | 1.0 |
For the SONN stock predictions from the analysts covering Sonnet BioTherapeutics Holdings Inc, we have collected all of the individual SONN stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 1 different analysts covering SONN (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since SONN stock predictions may vary widely, another useful metric to consider is the median SONN stock prediction, which represents the price at which half of the analysts
made SONN stock predictions that were higher and half made SONN stock predictions that were lower. This makes for a different take on the SONN stock predictions out there, as compared to average or mean.
And that median across all the individual SONN stock predictions was: $240.0 as of 2024-10-10.
The very highest of the SONN stock predictions for one year price target was $240.0, while the very lowest of the SONN stock predictions in the analyst group was
$240.0 (with a standard deviation of $0.0). Get the latest Zacks research report on SONN — FREE
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
NKLA Stock Predictions
DOYU Stock Predictions
GLPI Stock Predictions
AT Stock Predictions
AEE Stock Predictions
HT Stock Predictions
SPXC Stock Predictions
WAFD Stock Predictions
PVG Stock Predictions
|
|
Strong Buy (4.00 out of 4) 82nd percentile
(ranked higher than approx. 82% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |